The tympanostomy products market is set to reach from US$ 79.3 Mn in 2017 to US$ 93.4 Mn in 2026 showcasing sluggish growth at a compounded annual growth rate of 1.9% during the forecast period from 2018 to 2026. As per the latest research citing provided by World Health Organization (WHO), annually approximately 709 million people throughout the globe are suffering with otitis media in which 90% are children.
"Introduction of novel devices and lack of general anesthesia in insertion and removal increases the adoption rate of tube inserters among ENT surgeons"
Tube inserters are leading the product segment for tympanostomy products market. The major factors responsible for its increased adoption rate among ENT surgeons worldwide is introduction of novel inserters and lack of general anesthesia in insertion and removal of tube inserters while treating recurrent otitis media with effusion infection in pediatric patients. Tympanostomy tubes will register impressive growth in the near future due to availability in various designs, bioresorbable and antimicrobial coated tubes for treating middle ear infections.
"Inherent features such as biocompatibility, beveled share resisting occlusion and smoothness drive the fluoroplastic material market growth"
In the current scenario fluoroplastic material are reigning the material segment for tympanostomy products market. Inherent features such as beveled shape resisting occlusion, smoothness and excellent biocompatibility drive the market growth for fluoroplastic tympanostomy material. Silicone materials have huge demand owing to its physic-chemical properties such as compliant, elastic and softness makes its manipulation easy. It’s extremely lubricious nature makes insertion and removal of tympanostomy products easy and safe.reasing preference for tympanostomy procedure drive the recurrent otitis media with effusion market growth"
Recurrent otitis media with effusion is leading the application segment for tympanostomy products market. Parameters such as increasing preference for tympanostomy procedures and emerging problem of antibiotic resistance drive the market growth for recurrent otitis media with effusion. Chronic otitis media is highly prevalent in pediatric patients with upper respiratory tract infection often resulting in redness of tympanic membrane. Accurate diagnosis with proper medical intervention is the best possible option to prevent mucoid or purulent effusion form the middle ear region.
"Rising prevalence of otitis media infection in children and domicile of key players drive the market growth in North America"
In the present scenario North America dominates the regional segment for tympanostomy products market. It holds 35% market share primarily due to rising prevalence of otitis media infection in children. As per the research findings obtained by United States Agency for Healthcare and Quality, approximately 1 million tube insertion procedures are conducted annually in U.S. Domicile of key players such as Atos Medical, Medtronic Plc., and Olympus Corporation further consolidate the market growth in North America region. Europe represents 25% market share on account of the affordable reimbursement scenario for tympanostomy products and supportive regulatory environment provided by the European Medical Agency (EMA). Asia Pacific currently is accountable for 15% market share and will be the fastest growing market during the forecast period owing to the rising prevalence of middle ear infection and significant rise in medical tourism.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
Tympanostomy products market segmentation is as follows:
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2016 to 2026 |
| Base Year | 2017 |
| Forecast Period | 2018-2026 |
| Historical Year | 2016 |
| Unit | USD Million |
| Segmentation |
By Product (2016–2026; US$ Mn) |
|
By Material (2016–2026; US$ Mn) |
|
|
By Application (2016–2026; US$ Mn) |
|
|
Geography Segment (2016–2026; US$ Mn) |
Major medical device manufacturers producing tympanostomy products are Atos Medical, Adept Medical, EON Meditech, Koken Co., Ltd., Medtronic, Plc., OtoMedics Advanced Medical Technologies, Olympus Corporation, Preceptis Medical, Summit Medical Group and Teleflex Incorporated.
